Recent News

• 05.29.2025 - Novavax to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
• 05.29.2025 - Novavax to Participate in Jefferies Global Healthcare Conference
• 05.07.2025 - Novavax to Participate in BofA Securities 2025 Health Care Conference
• 05.01.2025 - Novavax to Report First Quarter 2025 Financial Results on May 8, 2025
• 04.21.2025 - World Vaccine Congress: The potential of Novavax’s technology platform and Matrix-M® adjuvant

Recent Filings

• 05.27.2025 - 8-K Current report
• 05.19.2025 - 8-K Current report
• 05.19.2025 - 144 Report of proposed sale of securities
• 05.08.2025 - EX-99.1 EX-99.1
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.08.2025 - 8-K Current report
• 05.05.2025 - 8-K Current report
• 04.30.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.29.2025 - ARS Annual Report to Security Holders
• 04.29.2025 - 8-K Current report